Identification and validation of miRNA-target genes network in pediatric brain tumors

Renata Gruszka1, Jakub Zakrzewski2, Emilia Nowosławska3

  • 1Faculty of Biology and Environmental Protection, Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha 12/16, 90-237, Lodz, Poland. renata.gruszka@biol.uni.lodz.pl.

Scientific Reports
|August 2, 2024
PubMed

Insights

MicroRNA alterations in childhood brain tumors reveal potential therapeutic targets. Gene expression analysis identified key genes regulated by OncomiR-1, correlating with tumor grade and subtype.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA (miRNA) alterations are implicated in cancer, affecting cellular processes and offering potential for combination therapies, including in brain tumors.
  • Advances in brain tumor genetics and epigenetics necessitate continuous knowledge updates and classification refinement.

Purpose of the Study:

  • To conduct molecular analysis of childhood brain tumors (pilocytic astrocytoma, medulloblastoma, ependymoma).
  • To identify genes potentially regulated by OncomiR-1 members (miR-17-5p and miR-20a-5p).

Main Methods:

  • Microarray gene expression analysis and quantitative reverse transcription PCR (qRTPCR) profiling.
  • Analysis of 123 childhood brain tumor samples.
  • Selection of six candidate target genes: WEE1, CCND1, VEGFA, PTPRO, TP53INP1, BCL2L11.

Main Results:

  • WEE1, CCND1, PTPRO, and TP53INP1 genes exhibited increased expression across all tested tumor types.
  • Pilocytic astrocytoma showed a lower increase in these genes compared to ependymoma and medulloblastoma.
  • Gene expression levels correlated with World Health Organization (WHO) grade and tumor subtype.

Conclusions:

  • The findings suggest that integrated genomic and epigenetic pathway analysis is crucial for future molecular research in brain tumors.
  • Identified gene expression patterns offer insights into potential therapeutic strategies and molecular classification of childhood brain tumors.